RCIM
CELG

Russell Clark Investment Management’s Celgene Corp CELG Stock Holding History

Russell Clark Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,000
Closed -$894K – 48
2019
Q3 		$894K Hold
9,000
– – 0.71% 41
2019
Q2 		$832K Hold
9,000
– – 0.53% 41
2019
Q1 		$849K Hold
9,000
– – 0.29% 41
2018
Q4 		$577K Hold
9,000
– – 0.21% 34
2018
Q3 		$805K Hold
9,000
– – 0.19% 63
2018
Q2 		$715K Hold
9,000
– – 0.14% 63
2018
Q1 		$803K Hold
9,000
– – 0.16% 70
2017
Q4 		$939K Buy
9,000
+3,000
+50% +$339K 0.2% 64
2017
Q3 		$875K Hold
6,000
– – 0.19% 59
2017
Q2 		$779K Buy
+6,000
New +$735K 0.22% 57

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Russell Clark Investment Management's CELG Position: Q4 2019 in Review

Russell Clark Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,000 shares — an estimated $894K sold.

Russell Clark Investment Management first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $939K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Russell Clark Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Russell Clark Investment Management sold 9,000 Celgene Corp shares in Q4 2019, an estimated $894K.
  • Russell Clark Investment Management first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • Russell Clark Investment Management's Celgene Corp position peaked at $939K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Russell Clark Investment Management's 13F filing for Q4 2019, filed 11 Feb 2020.